๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Acute Myocardial Infarction (AMI)
Clinical trial register · China

Acute Myocardial Infarction (AMI) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 5 Beijing 4 Nanjing 2 Xuzhou 2 Chongqing 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai5 Beijing4 Nanjing2 Xuzhou2 Chongqing2
All 26 locations
Target enrolment
to

Acute Myocardial Infarction (AMI) trials in China

19 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Prospective Cohort Study of Aging in Patients With Acute Myocardial Infarction
NCT07705997Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Hangzhou Normal University
Observational
600
Hanzhou
2026-08-01
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University
Not applicable
2,000
Harbin, Beijing, Cangzhou, Chengde, Chengdu, Dalian, Daqing, Hunan
2026-07-13
Not yet open
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
NCT07586865Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall, Acute Myocardial Infarction With ST Elevation, Acute Myocardial Infarction of Left Ventricle
Beijing Northland Biotech. Co., Ltd.
Phase 2
189
Beijing
2026-05-18
Not yet open
Prospective Lifespan Cohort of Myocardial Infarction
NCT07471763Acute Myocardial Infarction (AMI), Stable Angina, Unstable Angina
Fujian Provincial Hospital
Observational
6,000
Fuzhou
2026-04-10
Not yet open
IABP for MI-VSD Patients in SCAI SHOCK Stage B
NCT07267884Acute Myocardial Infarction (AMI), Ventricular Septal Defects (VSD)
Qilu Hospital of Shandong University
Not applicable
100
Jinan
2026-02-28
Recruiting
Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction
NCT07537296Acute Myocardial Infarction (AMI)
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Nanjing
2026-01-01
Recruiting
Very Early PCSK9 Inhibition for Acute Myocardial Infarction
NCT07208006Acute Myocardial Infarction (AMI)
Shanghai Zhongshan Hospital
Not applicable
1,518
Shanghai
2026-01-01
Not yet open
Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients
NCT06683131Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Phase 4
1,160
Fuyang, Huai'an, Lianyungang, Nanjing, Suqian, Xuzhou, Beijing, Shanghai
2025-11-20
Not yet open
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
NCT07153744Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
Shanghai Hutchison Pharmaceuticals Limited
Phase 4
9,588
Shanghai
2025-09-01
Active, closed
Acute Myocardial Infarction Prediction Using Artificial Intelligence Applied to Electrocardiogram Images
NCT07163767Acute Myocardial Infarction (AMI), Electrocardiography, Artifical Intelligence
Guangdong Provincial People's Hospital
Observational
150,000
Guangzhou
2025-08-01
Recruiting
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
NCT07130409Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), PET / MR
The Affiliated Hospital of Qingdao University
Observational
20
Qingdao
2025-08
Recruiting
Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury
NCT07023679Acute Myocardial Infarction (AMI)
The Second Hospital of Anhui Medical University
Not applicable
2,588
Hefei
2025-06-24
Not yet open
Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction
NCT06812546Heart Failure, Acute Myocardial Infarction (AMI), Acute Heart Failure (AHF)
Dongying Zhang
Phase 4
200
Chongqing
2025-04-01
By invitation
POCT Detection for Blood Concentration of Tirofiban in Acute Myocardial Infarction Based on Azo-POP Probe.
NCT06836531Acute Myocardial Infarction (AMI)
First Affiliated Hospital of Ningbo University
Observational
100
Ningbo
2025-03-30
Active, closed
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Novo Nordisk A/S
Phase 3
10,000
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Cangzhou, Shijiazhuang, Harbin
2024-06-25
Recruiting
Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients
NCT07042321Acute Myocardial Infarction (AMI)
The Third Xiangya Hospital of Central South University
Observational
300
Changsha
2024-06-01
By invitation
Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases
NCT06690684Angiocardiography, Heart Failure, Ischemic Heart Disease, Acute Myocardial Infarction (AMI)
Ya-Wei Xu
Observational
300
Shanghai
2023-10-17
Recruiting
Myocardial Infarction and Periodontitis: Periodontal Health Intervention.
NCT06745141Acute Myocardial Infarction (AMI), Periodontal Disease
Shanghai 10th People's Hospital
Not applicable
100
Shanghai
2020-12-01
Active, closed
Early CMR in Acute MI
NCT07602439Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Observational
2,000
Xuzhou
2018-10-31
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/acute-myocardial-infarction-ami

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies listing the condition Acute Myocardial Infarction (AMI).

How many Acute Myocardial Infarction (AMI) trials are recruiting in China?

7 of the 19 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 7 have not yet opened recruitment, 3 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Acute Myocardial Infarction (AMI)), 19 studies
PhaseStudiesRecruitingShare
Observational9347.4%
Not applicable5426.3%
Phase 43015.8%
Phase 2105.3%
Phase 3105.3%

Most active sponsors

Lead sponsors with the most studies (Acute Myocardial Infarction (AMI))
Lead sponsorStudiesRecruiting
The Affiliated Hospital of Xuzhou Medical University20
Beijing Northland Biotech. Co., Ltd.10
Dongying Zhang10
First Affiliated Hospital of Ningbo University10
Fujian Provincial Hospital10
Guangdong Provincial People's Hospital10
Harbin Medical University11
Nanjing First Hospital, Nanjing Medical University11
Novo Nordisk A/S10
Qilu Hospital of Shandong University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.